Medexus Pharmaceuticals Quote - MDP | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Canada
TSXV
Medexus Pharmaceuticals Inc (MDP) Share Price

Medexus Pharmaceuticals Inc (MDP)

7.75

0.00

(0.00%)

Closed November 23 3:00PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

7.75

Bid

7.80

Ask

7.85

Volume

-

0.00 Day's Range 0.00

7.75 52 Week Range 7.75

Market Cap

Previous Close

7.75

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

24,458,000

Dividend Yield

-

PE Ratio

-281.61

Earnings Per Share (EPS)

-0.01

Revenue

113.05M

Net Profit

-214k

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Website

www.medexus.com

Headquarters

Bolton, Gbr

Founded

2013

Medexus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker MDP. The last closing price for Medexus Pharmaceuticals was $7.75. Over the last year, Medexus Pharmaceuticals shares have traded in a share price range of $ 7.75 to $ 7.75.

Medexus Pharmaceuticals currently has 24,458,000 shares outstanding. The market capitalization of Medexus Pharmaceuticals is $189.55 million. Medexus Pharmaceuticals has a price to earnings ratio (PE ratio) of -281.61.

Complete Response Letter Received from FDA for Treosulfan

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced...

Medexus Appoints New Chief Financial Officer

TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad...

Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in C...

TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered...

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of...

Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash equivalents of $18.7 million and available liquidity of $24.8 million at March 31, 2021...

Medexus Announces Graduation to the Toronto Stock Exchange

TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final...

Medexus to Present at Raymond James Human Health Innovation Conference

TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

Medexus Schedules Fiscal Year 2021 Conference Call

TORONTO and CHICAGO and MONTREAL, June 11, 2021 (GLOBE NEWSWIRE) -- , June 11, 2021 - Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today...

Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

TORONTO, CHICAGO and MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it...

Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	7.75	7.75	7.75	0	0	CS
4	0	0	7.75	7.75	7.75	0	0	CS
12	0	0	7.75	7.75	7.75	0	0	CS
26	0	0	7.75	7.75	7.75	0	0	CS
52	0	0	7.75	7.75	7.75	0	0	CS
156	0	0	7.75	7.75	7.75	0	0	CS
260	3.9	101.298701299	3.85	9.75	1.42	8469	6.76809494	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GNFIGenifi Inc	$ 0.015 (200.00%)	154k
AVII.PAntera Ventures II Corp	$ 0.07 (180.00%)	1,000
MVYMoovly Media Inc	$ 0.01 (100.00%)	6.36k
CYFCanyon Creek Food Company Ltd	$ 0.025 (66.67%)	2k
SEVSpectra7 Microsystems Inc	$ 0.185 (54.17%)	284.14k
SSESilver Spruce Resources Inc	$ 0.005 (-50.00%)	40.31k
TVC.HThree Valley Copper Corp	$ 0.005 (-50.00%)	218k
CCDCascadero Copper Corporation	$ 0.005 (-50.00%)	7k
EKGCardioComm Solutions Inc	$ 0.005 (-50.00%)	257k
KLXCarbon Done Right Developments Inc	$ 0.01 (-33.33%)	412k
TVITVI Pacific Inc	$ 0.01 (0.00%)	9.25M
DMDataMetrex AI Limited	$ 0.005 (0.00%)	5.09M
DMGIDMG Blockchain Solutions Inc	$ 0.435 (6.10%)	3.16M
FUUF3 Uranium Corp	$ 0.235 (0.00%)	3.09M
THRMTherma Bright Inc	$ 0.025 (0.00%)	2.53M

TRAPPER JIM

TRAPPER JIM 6 minutes ago

Made all my deliveries and pickups today. I spackled the left side of the garage last night. Got up at 5:30 in the morning and sanded it. Then painted the first coat and went to work this morning. Came home and ate dinner. Then dozed off for a half hour. LOLOLOLOLOLOL went out and painted the second

Venture Point

Venture Point 6 minutes ago

Somebody call Adam and tell him to pivot to copying Microstrategy. Just issue debt and buy Bitcoin. No employees and no expenses. Just borrow money and buy Bitcoin with it.
Would solve so many problems and could be done immediately with no delay or name change. Announce it as a strategy and

Zorax

Zorax 7 minutes ago

Agree. I vacillated on that guy at first because of the talk of 'never losing a case', which now seems to be never losing a case that you chose to do and stay away from real ones. When garland didn't protest the criminal barr putting in new rulings about presidents, that they couldn't do against nix

Viking61

Viking61 20 minutes ago

Rick, I figured that you were in the restaurant business when you talked about a bus coming in and that you had go take care of it. Only those of us in the business know. Wish you the best!

Seminole Red

Seminole Red 22 minutes ago

now if Trump can get them all approved over the Dem Traps.....

quester614

quester614 24 minutes ago

What about the fact Xeriant SRO started in May of 2018. That's why I ask the question about the name that you say came from variant. Not whether or not the CTT SCAM ever got started. Just more diversion and distraction from you.

MartinLutherKing

MartinLutherKing 24 minutes ago

Moon landing coming next week 🚀🚀🚀🚀

nowwhat2

nowwhat2 27 minutes ago

13 HOURS LATER....... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175427571

https://investorshub.advfn.com/uimage/uploads/2024/11/23/bkygmDOGE_111111_22_30d_930pm_OHTL_BO_WATCH.jpg

https://investorshub.advfn.com/uimage/uploads/2024/11

blizzetrix

blizzetrix 27 minutes ago

Official website
https://www.cryptoalertscam.com/blizzetrix-reviews/
https://www.cryptoalertscam.com/novusx-trading/
https://www.cryptoalertscam.com/trade-fluxa-5-2-review/
https://www.cryptoalertscam.com/immediate-5-8-sprix-review/
https://www.facebook.com/blizzet

oldmystic

oldmystic 35 minutes ago

Jefferies says market nears short term “peak RFK negativity", Vaccine makers up
https://www.investing.com/news/stock-market-news/jefferies-says-market-nears-short-term-peak-rfk-negativity-vaccine-makers-up-3737884?utm_source=yahoo&utm_medium=referral&utm_campaign=yahoo_finance

king_kong

king_kong 36 minutes ago

I don't think they would bring in pink unless they have something because it cost money for them to do all the fillings.

dstock07734

dstock07734 37 minutes ago

Betting? You mean something like gambling?

How could I have full conviction that this is a completely derisked investment? Does your friend know what the best medicine looks like?

You can forget about BO. It won't happen.

bluebird50

bluebird50 38 minutes ago

I'm embarrassed to say the amount of money I've pushed into penny stocks before.... lol

Just checking in.... great day it looks here!

I have what I consider a very small position here.

gorbec1

gorbec1 38 minutes ago

Well than guess we won’t see you again have a good life

Doc logic

Doc logic 42 minutes ago

flipper44,

Poly might be used during L activation/maturation at a later date to improve or guide uptake of tumor derived or associated antigens which might reduce the amount of tumor tissue needed to make vaccines with. For the time being we know it will be used as it was in the tria

Moonboy1

Moonboy1 45 minutes ago

Haha. More bag holders that like staying poor.

Denn55

Denn55 50 minutes ago

It appears that they did make some purchases, but I think some of those purchases have not begun to add much to the bottom line yet. Their NAV has dropped drastically.

BornAgain

BornAgain 54 minutes ago

I guess Sam wants to buy a new car, That's great for him. He deserves it.

https://ih.advfn.com/stock-market/USOTC/innovative-food-qb-IVFH/stock-news/94974374/form-4-statement-of-changes-in-beneficial-owners

harpe5368

harpe5368 60 minutes ago

Maybe! maybe not. I don't no. I know there still in business and trying to move forward on multiple fronts. shares are trading, so someone has to be buying them for what ever reason. Not a lot of $ but ?...........

Doc logic

Doc logic 1 hour ago

tryn2,

Good to have you back again. Good time to bring out the old mantra “stay tuned”; ). Looks like anytime up to about 4 weeks for ruling on motion to dismiss and from now up to 9 weeks for MHRA decision seems most likely. Best wishes.

Medexus Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions